Abstract
Superantigens interact with major histocompatibility complex (MHC) class II molecules and T-cell receptors (TcRs) forming a trimolecular complex which is able to induce proliferation and cytokine production in T cells. Although superantigens appear to act through a common mechanism, they vary in many of their specific interactions and biological properties. X-ray crystallographic studies and biochemical experiments have now established that cross-linking of MHC class II molecules and the TcR by superantigens can occur in a number of different modes.
| Original language | English |
|---|---|
| Pages (from-to) | 991-996 |
| Number of pages | 6 |
| Journal | Structure |
| Volume | 5 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - 15 Aug 1997 |
Funding
We thank Howard Tranter, Vasanta Subramanian and Laurence Irons for stimulating discussions and the Medical Research Council (UK) for financial support.
ASJC Scopus subject areas
- Structural Biology
- Molecular Biology
Fingerprint
Dive into the research topics of 'Superantigens as immunomodulators: Recent structural insights'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS